These tumors with homologous repair deficiency and treated with PARPi are characterized by high genomic instability, and high numbers of DNA breaks, thus generating dsDNA fragments able to activate the interferon pathway (and thus increased MHC expression) in treated cancer cells by stimulating the STING (Stimulator of Interferon Genes) pathway [60,61]. The gene discussed is STING1; the disease is cancer.